ChemoCentryx: Analyst Day (Chemocentryx) - May 29, 2013 - "Vercirnon, But Not Placebo, Exhibited a CDAI Remission Rate of ~50% During Maintenance Period"; "4% Vercirnon Subjects in Steroid-Free CDAI Remission at Week 52 (P < 0.05)"
P2 data • Crohn's Disease • Immunology • Inflammatory Bowel Disease
|